| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/29/2007 | CA2197673C Drugs to improve synaptic transmission |
| 05/29/2007 | CA2190659C Taxoids, preparation and pharmaceutical compositions containing them |
| 05/29/2007 | CA2173317C Pharmaceutically acceptable polymeric tissue coating |
| 05/29/2007 | CA2168080C Process for the preparation of 1-(2'-deoxy-2',2'-difluoro- d-ribopentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro- beta-d-ribo-pentopyranose |
| 05/29/2007 | CA2090612C Method of reversing local anesthesia and reagent system therefor |
| 05/24/2007 | WO2007059515A2 Compositions of lipoxygenase inhibitors |
| 05/24/2007 | WO2007059500A2 Novel process and formulations |
| 05/24/2007 | WO2007059482A2 Modulation of immune responses |
| 05/24/2007 | WO2007059445A2 Synergistic combinations of norketamine and opioid analgesics |
| 05/24/2007 | WO2007059435A2 Compositions and methods for enhancing cognitive function |
| 05/24/2007 | WO2007059431A1 Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs |
| 05/24/2007 | WO2007059422A2 Pharmaceutical formulations containing 5-cyclopropyl-2(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and method of making same |
| 05/24/2007 | WO2007059421A2 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same |
| 05/24/2007 | WO2007059356A2 Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1 |
| 05/24/2007 | WO2007059330A2 Cubane nucleoside analogs |
| 05/24/2007 | WO2007059329A2 Methods and compositions for treating cancer |
| 05/24/2007 | WO2007059323A2 Certain chemical entities, compositions, and methods |
| 05/24/2007 | WO2007059311A2 Furoxan compounds, compositions and methods of use |
| 05/24/2007 | WO2007059299A1 Aminopyrimidines useful as kinase inhibitors |
| 05/24/2007 | WO2007059296A2 Ligands for mineralocorticoid receptor (mr) and methods for screening for or designing mr ligands |
| 05/24/2007 | WO2007059242A1 Low-density lipoprotein receptor-related protein 2 clears amyloid-beta peptide a cross the blood-brian barrier via apolipoprotein j |
| 05/24/2007 | WO2007059229A1 Hiv integrase inhibitors |
| 05/24/2007 | WO2007059226A2 Photoactivatable antimicrobial agents |
| 05/24/2007 | WO2007059219A1 Azaindazoles useful as inhibitors of kinases |
| 05/24/2007 | WO2007059195A1 Integrin-binding small molecules |
| 05/24/2007 | WO2007059188A1 Method for treating joint damage |
| 05/24/2007 | WO2007059157A1 Bisamide inhibitors of hedgehog signaling |
| 05/24/2007 | WO2007059155A1 Treatment of cancers having resistance to chemotherapeutic agents |
| 05/24/2007 | WO2007059154A2 Treatment of cancers with acquired resistance to kit inhibitors |
| 05/24/2007 | WO2007059145A2 Process for metabolic control and high solute clearance and solutions for use therein |
| 05/24/2007 | WO2007059125A2 Hiv integrase inhibitors |
| 05/24/2007 | WO2007059118A1 Combretastatin derivatives and related therapeutic methods |
| 05/24/2007 | WO2007059113A2 Certain chemical entities, compositions, and methods |
| 05/24/2007 | WO2007059111A2 Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents |
| 05/24/2007 | WO2007059108A2 Substituted quinolones and methods of use |
| 05/24/2007 | WO2007059106A2 Administration of mntor inhibitor to treat patients with cancer |
| 05/24/2007 | WO2007059099A2 Boroproline combination therapy for cancer |
| 05/24/2007 | WO2007059078A1 Treatment of multiple myeloma with dasatinib |
| 05/24/2007 | WO2007059047A2 Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements |
| 05/24/2007 | WO2007059041A2 Combinations and methods of using an immunomodulatory oligodeoxynucleotide |
| 05/24/2007 | WO2007059039A1 Thyroxine derivatives for preconditioning against stroke |
| 05/24/2007 | WO2007059021A1 Soft anticholinergic zwitterions |
| 05/24/2007 | WO2007059019A2 Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| 05/24/2007 | WO2007059008A2 N-substituted indenoisoquinolines and syntheses thereof |
| 05/24/2007 | WO2007058995A1 Manually actuated contactless card |
| 05/24/2007 | WO2007058992A2 Mutations and polymorphisms of hdac6 |
| 05/24/2007 | WO2007058991A2 Mutations and polymorphisms of c-abl |
| 05/24/2007 | WO2007058990A2 Therapy using cytokine inhibitors |
| 05/24/2007 | WO2007058960A1 Sulfamoyl benzamides as cannabinoid receptor modulators |
| 05/24/2007 | WO2007058935A2 Ophthalmic composition for dry eye therapy |
| 05/24/2007 | WO2007058927A1 Histone deacetylase inhibitors as therapeutics for neurological diseases |
| 05/24/2007 | WO2007058894A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 05/24/2007 | WO2007058862A2 Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/24/2007 | WO2007058852A2 Inhibitors of akt activity |
| 05/24/2007 | WO2007058850A2 Inhibitors of akt activity |
| 05/24/2007 | WO2007058805A2 Compositions and methods for treating cns disorders |
| 05/24/2007 | WO2007058801A1 Pharmaceutical compositions for the administration of aptamers |
| 05/24/2007 | WO2007058800A2 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 05/24/2007 | WO2007058664A1 Atorvastatin formulation |
| 05/24/2007 | WO2007058663A2 Recombinant bcg strains with enhanced ability to escape the endosome |
| 05/24/2007 | WO2007058646A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| 05/24/2007 | WO2007058634A1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 05/24/2007 | WO2007058630A1 Novel bis(amino)-ortho-dicarbaborane cluster compounds |
| 05/24/2007 | WO2007058628A1 Heteroalkyl linked pyrimidine derivatives |
| 05/24/2007 | WO2007058627A1 Oxygen linked pyrimidine derivatives |
| 05/24/2007 | WO2007058626A1 Indazole compounds |
| 05/24/2007 | WO2007058612A1 Medicament for use in connection with cartilage impairment |
| 05/24/2007 | WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 05/24/2007 | WO2007058601A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia |
| 05/24/2007 | WO2007058593A1 Quetiapine in a controlled release formulation |
| 05/24/2007 | WO2007058583A2 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 05/24/2007 | WO2007058582A1 Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use |
| 05/24/2007 | WO2007058581A1 Novel 2-aminopyrimidine derivatives and their use |
| 05/24/2007 | WO2007058580A1 Novel 2-aminopyrimidinone derivatives and their use |
| 05/24/2007 | WO2007058523A1 Composition with docosapentaenoic acid |
| 05/24/2007 | WO2007058504A1 Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
| 05/24/2007 | WO2007058498A1 Compositions for peritoneal dialysis |
| 05/24/2007 | WO2007058482A1 Novel inhibitors of protein kinase |
| 05/24/2007 | WO2007058480A1 Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin |
| 05/24/2007 | WO2007058394A1 Medicinal composition comprising 3-alkoxy-6-allylthiopyridazines for prevention or treatment of cancer of the pancreas |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007058384A1 Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same |
| 05/24/2007 | WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/24/2007 | WO2007058338A2 Oxazole compound and pharmaceutical composition |
| 05/24/2007 | WO2007058336A1 SCREENING METHOD AND IDENTIFICATION METHOD FOR SUBSTANCE CAPABLE OF INHIBITING DEGRANULATION REACTION OR PROSTAGLANDIN D2 PRODUCTION IN MAST CELL THROUGH Rec168, AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE COMPRISING THE SUBSTANCE |
| 05/24/2007 | WO2007058335A1 Use of tak-475 together with ezetimibe for treating hyperlipidemia |
| 05/24/2007 | WO2007058323A1 Method for production of nucleic acid homopolymer-bound functional nucleic acid medicine |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007058305A1 Process for production of cinnamamide derivative |
| 05/24/2007 | WO2007058304A1 Salts of cynnamide compound or solvates thereof |
| 05/24/2007 | WO2007057909A1 Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies |
| 05/24/2007 | WO2007057889A2 Succinimide derivatives as ocular hypotensive agents |
| 05/24/2007 | WO2007057849A2 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use |
| 05/24/2007 | WO2007057775A1 Spiropiperidine derivatives |
| 05/24/2007 | WO2007057767A2 Amino acid derivatives |
| 05/24/2007 | WO2007057756A2 Isocystene derivatives for the treatment of pain |
| 05/24/2007 | WO2007057755A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium |
| 05/24/2007 | WO2007057742A2 Novel piperazinone derivatives |
| 05/24/2007 | WO2007057714A2 Pharmaceutical compositions comprising methotrexate |
| 05/24/2007 | WO2007057705A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr) |